Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes

W. Ken Redekop, Marc A. Koopmanschap, Ronald P. Stolk, Guy E H M Rutten, Bruce H R Wolffenbuttel, Louis Niessen

Research output: Contribution to journalArticle

Abstract

OBJECTIVE - To estimate the health-related quality of life (HRQOL) and treatment satisfaction for patients with type 2 diabetes in the Netherlands and to examine which patient characteristics are associated with quality of life and treatment satisfaction. RESEARCH DESIGN AND METHODS - For a sample of 1,348 type 2 diabetes patients, recruited by 29 general practitioners, we collected data regarding HRQOL. This study was performed as part of a larger European study (Cost of Diabetes in Europe - Type 2 [CODE-2]). We used a generic instrument (Euroqol 5D) to measure HRQOL. Treatment satisfaction was assessed using the Diabetes Treatment Satisfaction Questionnaire. RESULTS - Patients without complications had an HRQOL (0.74) only slightly lower than similarly aged persons in the general population. Insulin therapy, obesity, and complications were associated with a lower HRQOL, independent of age and sex. Although higher fasting blood glucose and HbA1c levels were negatively associated with HRQOL, these factors were not significant after adjustment for other factors using multivariate analysis. Overall treatment satisfaction was very high. Younger patients, patients using insulin, and patients with higher HbA1c levels were less satisfied with the treatment than other patients. CONCLUSIONS - Obesity and the presence of complications are important determinants of HRQOL in patients with type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)458-463
Number of pages6
JournalDiabetes Care
Volume25
Issue number3
DOIs
StatePublished - Mar 2002
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Quality of Life
Therapeutics
Obesity
Insulin
Patient Satisfaction
Netherlands
General Practitioners
Blood Glucose
Fasting
Research Design
Multivariate Analysis
Costs and Cost Analysis
Population

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E. H. M., Wolffenbuttel, B. H. R., & Niessen, L. (2002). Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care, 25(3), 458-463. https://doi.org/10.2337/diacare.25.3.458

Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. / Redekop, W. Ken; Koopmanschap, Marc A.; Stolk, Ronald P.; Rutten, Guy E H M; Wolffenbuttel, Bruce H R; Niessen, Louis.

In: Diabetes Care, Vol. 25, No. 3, 03.2002, p. 458-463.

Research output: Contribution to journalArticle

Redekop, WK, Koopmanschap, MA, Stolk, RP, Rutten, GEHM, Wolffenbuttel, BHR & Niessen, L 2002, 'Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes', Diabetes Care, vol. 25, no. 3, pp. 458-463. https://doi.org/10.2337/diacare.25.3.458
Redekop, W. Ken ; Koopmanschap, Marc A. ; Stolk, Ronald P. ; Rutten, Guy E H M ; Wolffenbuttel, Bruce H R ; Niessen, Louis. / Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. In: Diabetes Care. 2002 ; Vol. 25, No. 3. pp. 458-463.
@article{ec9be8f1314d44ebbf15c9d86a2bbb92,
title = "Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes",
abstract = "OBJECTIVE - To estimate the health-related quality of life (HRQOL) and treatment satisfaction for patients with type 2 diabetes in the Netherlands and to examine which patient characteristics are associated with quality of life and treatment satisfaction. RESEARCH DESIGN AND METHODS - For a sample of 1,348 type 2 diabetes patients, recruited by 29 general practitioners, we collected data regarding HRQOL. This study was performed as part of a larger European study (Cost of Diabetes in Europe - Type 2 [CODE-2]). We used a generic instrument (Euroqol 5D) to measure HRQOL. Treatment satisfaction was assessed using the Diabetes Treatment Satisfaction Questionnaire. RESULTS - Patients without complications had an HRQOL (0.74) only slightly lower than similarly aged persons in the general population. Insulin therapy, obesity, and complications were associated with a lower HRQOL, independent of age and sex. Although higher fasting blood glucose and HbA1c levels were negatively associated with HRQOL, these factors were not significant after adjustment for other factors using multivariate analysis. Overall treatment satisfaction was very high. Younger patients, patients using insulin, and patients with higher HbA1c levels were less satisfied with the treatment than other patients. CONCLUSIONS - Obesity and the presence of complications are important determinants of HRQOL in patients with type 2 diabetes.",
author = "Redekop, {W. Ken} and Koopmanschap, {Marc A.} and Stolk, {Ronald P.} and Rutten, {Guy E H M} and Wolffenbuttel, {Bruce H R} and Louis Niessen",
year = "2002",
month = "3",
doi = "10.2337/diacare.25.3.458",
language = "English (US)",
volume = "25",
pages = "458--463",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes

AU - Redekop, W. Ken

AU - Koopmanschap, Marc A.

AU - Stolk, Ronald P.

AU - Rutten, Guy E H M

AU - Wolffenbuttel, Bruce H R

AU - Niessen, Louis

PY - 2002/3

Y1 - 2002/3

N2 - OBJECTIVE - To estimate the health-related quality of life (HRQOL) and treatment satisfaction for patients with type 2 diabetes in the Netherlands and to examine which patient characteristics are associated with quality of life and treatment satisfaction. RESEARCH DESIGN AND METHODS - For a sample of 1,348 type 2 diabetes patients, recruited by 29 general practitioners, we collected data regarding HRQOL. This study was performed as part of a larger European study (Cost of Diabetes in Europe - Type 2 [CODE-2]). We used a generic instrument (Euroqol 5D) to measure HRQOL. Treatment satisfaction was assessed using the Diabetes Treatment Satisfaction Questionnaire. RESULTS - Patients without complications had an HRQOL (0.74) only slightly lower than similarly aged persons in the general population. Insulin therapy, obesity, and complications were associated with a lower HRQOL, independent of age and sex. Although higher fasting blood glucose and HbA1c levels were negatively associated with HRQOL, these factors were not significant after adjustment for other factors using multivariate analysis. Overall treatment satisfaction was very high. Younger patients, patients using insulin, and patients with higher HbA1c levels were less satisfied with the treatment than other patients. CONCLUSIONS - Obesity and the presence of complications are important determinants of HRQOL in patients with type 2 diabetes.

AB - OBJECTIVE - To estimate the health-related quality of life (HRQOL) and treatment satisfaction for patients with type 2 diabetes in the Netherlands and to examine which patient characteristics are associated with quality of life and treatment satisfaction. RESEARCH DESIGN AND METHODS - For a sample of 1,348 type 2 diabetes patients, recruited by 29 general practitioners, we collected data regarding HRQOL. This study was performed as part of a larger European study (Cost of Diabetes in Europe - Type 2 [CODE-2]). We used a generic instrument (Euroqol 5D) to measure HRQOL. Treatment satisfaction was assessed using the Diabetes Treatment Satisfaction Questionnaire. RESULTS - Patients without complications had an HRQOL (0.74) only slightly lower than similarly aged persons in the general population. Insulin therapy, obesity, and complications were associated with a lower HRQOL, independent of age and sex. Although higher fasting blood glucose and HbA1c levels were negatively associated with HRQOL, these factors were not significant after adjustment for other factors using multivariate analysis. Overall treatment satisfaction was very high. Younger patients, patients using insulin, and patients with higher HbA1c levels were less satisfied with the treatment than other patients. CONCLUSIONS - Obesity and the presence of complications are important determinants of HRQOL in patients with type 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0036511286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036511286&partnerID=8YFLogxK

U2 - 10.2337/diacare.25.3.458

DO - 10.2337/diacare.25.3.458

M3 - Article

C2 - 11874930

AN - SCOPUS:0036511286

VL - 25

SP - 458

EP - 463

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 3

ER -